Lung Cancer
Volume 66, Issue 3 , Pages 327-332, December 2009

Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer

  • Silvia Novello

      Affiliations

    • Department of Clinical & Biological Sciences, Thoracic Oncology Unit, University of Turin, Italy
    • Corresponding Author InformationCorresponding author at: University of Torino, Department of Clinical & Biological Sciences, Thoracic Oncology Unit, S. Luigi Hospital - Regione Gonzole 10, 10043 Orbassano (Torino), Italy. Tel.: +39 011 9026978; fax: +39 011 9038616.
  • ,
  • Alfredo Falcone

      Affiliations

    • Medical Oncology, Livorno, Italy
  • ,
  • Lucio Crinò

      Affiliations

    • Medical Oncology, Monteluce Hospital, Perugia, Italy
  • ,
  • Massimo Rinaldi

      Affiliations

    • Medical Oncology Division B, IRCCS Regina Hospital, Rome, Italy
  • ,
  • Mario Nardi

      Affiliations

    • Medical Oncology “Bianchi-Melacrino Morelli” Hospital, Reggio, Calabria, Italy
  • ,
  • Filippo De Marinis

      Affiliations

    • Thoracic Oncology Unit, San Camillo Forlanini Hospital, Rome, Italy
  • ,
  • Maurizio Tonato

      Affiliations

    • Medical Oncology, Monteluce Hospital, Perugia, Italy
  • ,
  • Carmelo Tibaldi

      Affiliations

    • Medical Oncology, Livorno, Italy
  • ,
  • Angelo Tinazzi

      Affiliations

    • SENDO Foundation, Milano, Italy
  • ,
  • Francesca Russo

      Affiliations

    • Medical Department, Eli Lilly Italy, Florence, Italy
  • ,
  • Nicoletta Grassivaro

      Affiliations

    • Medical Department, Sanofi Aventis, Milano, Italy
  • ,
  • Giorgio Vittorio Scagliotti

      Affiliations

    • Department of Clinical & Biological Sciences, Thoracic Oncology Unit, University of Turin, Italy

Received 7 October 2008; received in revised form 22 January 2009; accepted 15 February 2009. published online 31 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(09)00107-X

doi:10.1016/j.lungcan.2009.02.009

Lung Cancer
Volume 66, Issue 3 , Pages 327-332, December 2009